JNTUK B.Pharmacy 2-2 Sem (PCI,R16,R13) Regular/Supply Notification July 2023

Published on

JNTUK Whatsapp Channel

JNTUH Whatsapp Channel

JNTUA Whatsapp Channel

JNTUGV Whatsapp Channel

JNTUK B.Pharmacy 2-2 Notification 2023: JNTUK B.Pharmacy 2-2 Sem (PCI,R16,R13) Regular/Supply Notification July 2023, jntu kakinada 2-2 semester end examination fee notification 2023.

JNTUK B.Pharmacy 2-2 Sem (PCI,R16,R13) Regular/Supply Notification July 2023

JNTUK B.Pharmacy 2-2 Sem (PCI,R16,R13) Regular/Supply Notification July 2023

II B.PHARMACY II SEMESTER REGULAR/SUPPLEMENTARY EXAMINATIONS

  • PCI (For 2017 Admitted Batches onwards and 2018 Lateral Entry Admitted Batches onwards)
  • R16 (For 2016 Admitted Batches onwards and 2017 Lateral Admitted Batches onwards)
  • R13 (For 2015 Admitted Batch except lateral entry students)

CANDIDATES APPEARING FOR THE ABOVE EXAMINATIONS ARE INFORMED THAT THE APPLICATIONS WILL BE RECEIVED AS PER THE TIME SCHEDULE GIVEN BELOW:

  • Without Late Fee : 22-06-2023
  • With Late Fee of Rs.100/- : 24-06-2023
  • With Late fee of Rs.1000/- : 26-06-2023

EXAMINATION FEE

  • FOR WHOLE SEMESTER EXAMINATION (ALL SUBJECTS) Rs. 770/-
  • FOR ONE SUBJECT (THEORY/PRACTICAL) Rs. 265/-
  • FOR TWO SUBJECTS (THEORY/PRACTICAL) Rs. 390/-
  • FOR THREE SUBJECTS (THEORY/PRACTICAL) Rs. 515/-
  • FOR FOUR AND ABOVE SUBJECTS (THEORY/PRACTICAL) Rs. 770/-

Note:

  • Laboratory/Project Examinations schedule will be communicated later.
  • All the above Examinations will be conducted in jumbling system.
  • Applications should enclose the Xerox copies of latest marks memos containing details of failed subjects along with the applications.
  • Detailed Time Table for theory Examinations will notified in the J.N.T. University, Kakinada website. www.jntuk.edu.in www.jntukexams.net

JNTUK Notification For B.Pharmacy 2-2 Sem Reg/Supple Exams July-2023

71 COMMENTS

  1. sir, before jaregena 2-2 exam results Inka release chy ledu, ipudu 2-2 notification Ela release chystaru……?? please results paytandi..🙏🙏🙏

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest articles